ClinicalTrials.gg
TerminatedNCT00816270Updated Jan 1, 2009

Liquid Bandage (2-Octyl-Cyanoacrylate) in Upper Lid Blepharoplasty

An interventional study of Bilateral Upper eyelid blepharoplasty in Blepharoptosis, sponsored by Federal University of São Paulo. Terminated at 1 site in Brazil. Open to participants aged 25 Years to 70 Years. Per ClinicalTrials.gov, last updated 2009-01-01.

Sponsored by Federal University of São Paulo · Not applicable, Interventional, and Treatment

Why this study was terminated
Experimental results were unsatisfatory compared with control.
Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Randomized
Ages
25 Years to 70 Years
Sex
All
01

Study summary

The aim of this randomized and masked prospective trial is to compare the effectiveness of Liquid Bandage (Octyl-2-Cyanoacrylate) and 6/0 nylon suture as a wound closure device in upper lid blepharoplasty surgery.

Read the detailed description

Tissue adhesives have been safely used in a variety of surgical procedures for several years. Butyl-2-cyanoacrylate (Histoacryl) and Octyl-2-cyanoacrylate (Dermabond) was also studied for cosmetic blepharoplasty with satisfactory results. Liquid Bandage (Johnson \& Johnson, Skillman, NJ, USA) is a more flexible formulation of octyl-2-cyanoacrylate available in many american drugstores for home use. Animal models shown that this product could accelerate the healing of lamellar wounds and studies in humans have demonstrated its safety and effectiveness as an occlusive protective film over cuts, abrasion and wound surgery. Liquid Bandage was also used as a temporary wound barrier in clear corneal cataract surgery with satisfactory applicability. There is no study in the literature using this device in blepharoplasty yet.

02

Conditions studied

  • Blepharoptosis

Keywords

  • Blepharoptosis
  • Dermatochalasis
  • octyl 2-cyanoacrylate
  • Suture Techniques
  • Tissue Adhesive
03

In context

Blepharoptosis

63 studies on the registry are indexed under Blepharoptosis; 16 are open to participants now.

This study's enrollment of 11 is below the median of 45 across 50 interventional studies indexed under Blepharoptosis.

Browse Blepharoptosis studies →

Lead sponsor

Federal University of São Paulo is the lead sponsor of 438 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
25 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients older than 25 years with diagnosis of dermatochalasis who presented surgical indication of primary blepharoplasty.

Exclusion criteria

Exclusion Criteria:

  • Prior eyelid surgery
  • Concomitant ocular or systemic disease or current use of medications that could interfere in coagulation or wound healing (eg, diabetes mellitus, oral acetyl salicylic acid or corticosteroids)
  • Pregnant female
  • Known allergy to cyanoacrylate
  • Inability to return for follow-up consultations
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Single group
Masking
Double (Participant, Investigator)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    1

    Experimental operatory wound closure with liquid bandage (Johnson \& Johnson, Skillman, NJ, USA).

    Procedure: Bilateral Upper eyelid blepharoplasty

Interventions

  • ProcedureBilateral Upper eyelid blepharoplasty

    Bilateral upper lid blepharoplasty was performed on each patient by the same experimented surgeon using a standard technique. One side (right or left upper eyelid) was randomly chosen for experimental closure with liquid bandage and the opposite eyelid served as the control being used a 6/0 nylon continuous sutures.

    Also known as: Liquid bandage (Johnson & Johnson, Skillman, NJ, USA), nylon continuous sutures (Ethicon, Norderstedt, Germany)

06

What researchers measure

Primary outcomes

  1. The overall cosmetic outcome of wound closure technique (experimental: tissue adhesive Octyl-2-cyanoacrylate versus control: traditional nylon suture).

    Time frame: thirty days after surgery

07

Study locations

1 site
  • Department of Ophthalmology of Federal University of Sao Paulo
    São Paulo, São Paulo 04023-900, Brazil
08

References and documents

Publications

  • Veloudios A, Kratky V. Cyanoacrylate Tissue Adhesive in Blepharoplasty. Ophthalm Plastic Reconstr Surg 1996;12(2):89-97. Greene D, Koch RJ, Goode RL. Efficacy of Octyl-2-Cyanoacrylate Tissue Glue in Blepharoplasty. Arch Facial Plast Surg 1999;1:292-6. Davis SC, Eaglstein WH, Cazzaniga AL, Mertz PM. An octyl-2-cyanoacrylate formulation speeds healing of partial-thickness wounds. Dermatol Surg 2001;27:783-8.
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Apr 2008, a primary completion of Jul 2008 and a completion of Jul 2008. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 31, 2008
First posted
Jan 1, 2009
Start
Apr 2008
Primary completionActual
Jul 2008
CompletionActual
Jul 2008
Last update
Jan 1, 2009
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 1, 2009, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00816270
First posted
Jan 1, 2009
Start date
Apr 2008
Primary completion
Jul 2008
Completion
Jul 2008
Last update
Jan 1, 2009

Study contacts

Angelino J Cariello, MD
principal investigator · Federal University of São Paulo

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Dec 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion